ivWatch was founded by Gary Warren in 2010.

How much funding has ivWatch raised?

ivWatch has disclosed $105.3M raised across 7 rounds.

Where is ivWatch headquartered?

ivWatch is headquartered in Newport News, US.

ivWatch

Newport News, US · Founded 2010 · Virginia LLC

Find your way into ivWatch

Paths you didn't know you had: your email and LinkedIn already hold routes to the ivWatch team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ivWatch develops sensors and monitoring systems that detect peripheral IV infiltrations and extravasations at early stages to prevent patient harm in hospital settings. The company serves healthcare providers and hospitals globally through direct partnerships and a network of distributors.

Digital Health Hardware Healthtech Medical Devices

Founders & leadership

ivWatch was founded in 2010 by Gary Warren.

Gary Warren Founder, Member of the Board of ManagersGary Warren earned an engineering degree while interning at NASA, where he subsequently worked for 14 years before founding and selling a company to a public corporation. He has led multiple ventures as CEO and executive through high-growth stages in aerospace, internet infrastructure, mobile technology, and medical devices, including ivWatch, which developed an IV infiltration detection system recognized by Fast Company as a top global health innovation.

Holly Novak ExecutiveHolly Novak is an executive leader with over two decades of experience in quality assurance, regulatory affairs, and product development in the medical device, IVD, and biotech sectors. She has led quality management systems across 16 global regions and successfully obtained multiple regulatory clearances including 510(k) approvals, CE Marking, and MDSAP certification.

John ZwirschitzExecutive

Helen Stephens ExecutiveHelen Stephens holds a nursing background and brings 15+ years of medtech industry experience, including leadership roles at ICU Medical/Smiths Medical, Vygon, Carefusion, and Alaris Medical Systems, where she developed expertise in intravenous infusion delivery systems and hospital infusion therapy standards. She serves as Executive Officer at ivWatch.

Jaclyn Lautz ExecutiveJaclyn Lautz holds a Ph.D. in Mechanical Engineering and brings over 15 years of experience in medical device development, regulatory compliance, and operations. She has led product lifecycles from concept through FDA clearance and CE marking for Class II devices, built Quality Management Systems for FDA and ISO 13485 compliance, and previously advised pharmaceutical and life sciences clients on regulatory strategy at PwC.

Erin Wendell ExecutiveErin Wendell is an Executive Officer at ivWatch with nearly 20 years of experience in marketing communications and brand strategy across healthcare, technology, consumer, sports, and retail sectors.

F. Brian Clare Jr.Executive

Melissa FireExecutive

Gregory SchearsExecutive

MICHAEL GAHANExecutive

F. Brian Clare ExecutiveF. Brian Clare is an emergency medicine physician who has worked on early-stage healthcare companies focusing on clinical care delivery, operational efficiency, and financial performance. He serves as Executive Officer and Director at ivWatch, which develops sensors and monitoring systems to detect peripheral IV infiltrations and extravasations in hospital settings.

Chuck Egress ExecutiveChuck Egress held leadership positions at Symantec managing product development and business operations across enterprise security, gateway products, and a technology partner program, and previously worked in sales and product development roles at smaller companies before his acquisition involvement. He is now Executive Officer at ivWatch, which develops sensors and monitoring systems for detecting peripheral IV infiltrations in hospital settings.

Funding

SEC filings, press & company announcements

$105.3M disclosed across 7 rounds · 2014–2024

$14.8MraisedJun 2017 · 2 sources
Source ↗

▶$26.9MraisedSep 2024 · 16 investors · Other Health Care

Rule 506(b)